• Fri news: Gilead withdraws bladder cancer drug. Amgen and Intercept PDUFA date pushback. CVS replaces CEO. Supernus depression trial. AbbVie Parkinson’s approval. See more on our front page

Danny boy 0 for how many now?

anonymous

Guest
Hey Danny boy, it’s quite clear why Gtech showed you the door!! First your brilliant partnering with Galapagos at the tune of almost $5 bil!! Secondly, pricing of RDV at almost half of what ICER proposed and still got lambasted by the press!! And finally, $21bil for Immunomedics and now Keytruda with MTNBC indication!! I’m sure Andy will be the fall guy and Johanna will be ecstatic!!